Yiran Yao
Yiran Yao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ai Zhuang
Shanghai Jiaotong University School of Medicine, 200093,CHINA. State Key Laboratory of Eye health, Department of Ophthalmology,CHINA. Shanghai Ninth People's Hospital,CHINA. Shanghai Jiao Tong University School of Medicine, 200025,CHINA
1 shared publication - Ji Tan
State Key Laboratory of High Performance Ceramics, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, China
1 shared publication - Jun Shen
Division of Gastroenterology and Hepatology, Baoshan Branch, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Qi Feng
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Renbing Jia
Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
1 shared publication Ru Xu
State Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China
1 shared publication
Latest Publications
- Open Access
- 5 May 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , e2403107
A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation
Uveal melanoma (UM) is a leading intraocular malignancy with a high 5‐year mortality rate, and radiotherapy is the primary approach for UM treatment. However, the elevated lactic acid, deficiency in ROS, and hypoxic tumor microenvironment have severely reduced the radiotherapy outcomes. Hence, this study devised a novel CoMnFe‐layered double oxides (LDO) nanosheet with multienzyme activities for UM radiotherapy enhancement. On one hand, LDO nanozyme can catalyze hydrogen peroxide (H2O2) in the tumor microenvironment into oxygen and reactive oxygen species (ROS), significantly boosting ROS production during radiotherapy. Simultaneously, LDO efficiently scavenged lactic acid, thereby impeding the DNA and protein repair in tumor cells to synergistically enhance the effect of radiotherapy. Moreover, density functional theory (DFT) calculations decoded the transformation pathway from lactic to pyruvic acid, elucidating a previously unexplored facet of nanozyme activity. The introduction of this innovative nanomaterial paves the way for a novel, targeted, and highly effective therapeutic approach, offering new avenues for the management of UM and other cancer types.
- 5 May 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , e2403107
Open AccessA Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation
Uveal melanoma (UM) is a leading intraocular malignancy with a high 5‐year mortality rate, and radiotherapy is the primary approach for UM treatment. However, the elevated lactic acid, deficiency in ROS, and hypoxic tumor microenvironment have severely reduced the radiotherapy outcomes. Hence, this study devised a novel CoMnFe‐layered double oxides (LDO) nanosheet with multienzyme activities for UM radiotherapy enhancement. On one hand, LDO nanozyme can catalyze hydrogen peroxide (H2O2) in the tumor microenvironment into oxygen and reactive oxygen species (ROS), significantly boosting ROS production during radiotherapy. Simultaneously, LDO efficiently scavenged lactic acid, thereby impeding the DNA and protein repair in tumor cells to synergistically enhance the effect of radiotherapy. Moreover, density functional theory (DFT) calculations decoded the transformation pathway from lactic to pyruvic acid, elucidating a previously unexplored facet of nanozyme activity. The introduction of this innovative nanomaterial paves the way for a novel, targeted, and highly effective therapeutic approach, offering new avenues for the management of UM and other cancer types.
- 1 December 2020
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 16 (12) , 1127-1141
Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn’s disease
Researchers have investigated the potential role of intestinal permeability in Crohn’s disease pathogenesis. Intestinal permeability is usually mediated by cytoskeleton and intercellular junctions....
- 1 December 2020
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 16 (12) , 1127-1141
Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn’s disease
Researchers have investigated the potential role of intestinal permeability in Crohn’s disease pathogenesis. Intestinal permeability is usually mediated by cytoskeleton and intercellular junctions....